Concepedia

Cherri M. Miner

CM

Statistics

Publications

8

Citations

315

H-Index

8

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

Duke University

Duke University Hospital

Duke Medical Center

Cherri M. Miner is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacotherapy, and medicine.

Publications per year

1995–2004

8

Publications

8

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial

Cherri M. Miner, Eileen Brown, Susan McCray et al. · Clinical Therapeutics · 2002 · 94 citations

, , +17

Discontinuation of Clonazepam in the Treatment of Social Phobia

Kathryn M. Connor, Jonathan Davidson, Nicholas L.S. Potts et al. · Journal of Clinical Psychopharmacology · 1998 · 65 citations

, , +13

Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents

Mary Nilsson, Melissa J. Joliat, Cherri M. Miner et al. · Journal of Child and Adolescent Psychopharmacology · 2004 · 39 citations

, , +17

Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy

Stephanie C. Koke, Eileen B. Brown, Cherri M. Miner · American Journal of Obstetrics and Gynecology · 2002 · 30 citations

, , +12

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment

Teri Pearlstein, Melissa J. Joliat, Eileen B. Brown et al. · American Journal of Obstetrics and Gynecology · 2003 · 25 citations

, , +14

1–5 of 8